EP 0969852 A1 20000112 - COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND OBESITY
Title (en)
COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND OBESITY
Title (de)
KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON DIABETES UND FETTSUCHT
Title (fr)
THERAPIE PAR COMBINAISON D'AGENTS POUR LE TRAITEMENT DU DIABETE ET DE L'OBESITE
Publication
Application
Priority
- GB 9711042 A 19970529
- US 9719880 W 19971030
- US 2923396 P 19961031
Abstract (en)
[origin: WO9818481A1] The combination of a metabolic rate modifying agent (e.g., a beta 3 adrenergic receptor agonist) and a feeding behavior modifying agent (e.g., a NPY5 antagonist) is useful in the treatment of obesity and diabetes, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients. Methods of treating obesity and diabetes are also described.
IPC 1-7
A61K 38/00; A61K 31/55; A61K 31/495; A61K 31/44; A61K 31/47; A61K 31/445; A61K 38/22; A61K 45/06
IPC 8 full level
A61K 31/24 (2006.01); A61K 31/44 (2006.01); A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); C07K 14/575 (2006.01)
CPC (source: EP)
A61K 31/24 (2013.01); A61K 45/06 (2013.01); A61P 3/00 (2017.12); A61P 3/10 (2017.12); C07K 14/5759 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9818481 A1 19980507; AU 5160698 A 19980522; AU 723879 B2 20000907; AU 723879 C 20031106; CA 2269660 A1 19980507; EP 0969852 A1 20000112; EP 0969852 A4 20040506; JP 2002516605 A 20020604
DOCDB simple family (application)
US 9719880 W 19971030; AU 5160698 A 19971030; CA 2269660 A 19971030; EP 97946442 A 19971030; JP 52080398 A 19971030